HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body’s immune system. At HOOKIPA we are united by a set of core values and common beliefs which give meaning to our work and guide our daily behaviour. How we see the future:In the future, we envision a world in which medicines reinforce the natural ability of the body to prevent and cure serious diseases. What we do:We work to reprogram the immune system to more effectively combat cancer and infectious diseases.... weiterlesen

HOOKIPA Biotech GmbH

Pharma, Chemie, Biotech

Helmut-Qualtinger-Gasse 2/2
1030 Wien

Webseite